- Tel: 858.663.9055
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Dendritic Cell Antibody reagents target proteins expressed by dendritic cells (DCs), the specialized antigen-presenting cells that serve as sentinels of the immune system. Found in peripheral tissues such as skin, mucosa, and lymphoid organs, dendritic cells detect pathogens, capture antigens, and initiate adaptive immune responses. They bridge innate and adaptive immunity by presenting processed antigens to T cells, shaping immune tolerance and protective responses.
Dendritic cells are heterogeneous, encompassing conventional dendritic cells (cDC1 and cDC2), plasmacytoid dendritic cells (pDCs), and monocyte-derived dendritic cells. Each subset expresses unique surface markers such as CD11c, BDCA-2, CD123, and CLEC9A, in addition to MHC class II molecules. The Dendritic Cell Antibody provides researchers with powerful tools to study these populations, while Dendritic Cell Antibodies more broadly support immunology, infection biology, and cancer immunotherapy research.
NSJ Bioreagents offers Dendritic Cell Antibodies validated for immunohistochemistry, flow cytometry, western blotting, immunofluorescence, and ELISA. Each Dendritic Cell Antibody is rigorously tested for specificity to ensure accurate detection across human and model systems.
By selecting Dendritic Cell Antibodies from NSJ Bioreagents, researchers gain reagents optimized for reproducibility and clarity. Our antibodies provide strong staining in lymphoid tissues, reproducible detection in lysates, and robust results across multiple applications. Detailed datasheets, recommended controls, and validated protocols support accurate interpretation in both basic and translational research.
The Dendritic Cell Antibody is applied across diverse areas of immunology and clinical science.
Dendritic Cell Antibodies identify classical DC subsets in lymphoid and non-lymphoid tissues.
The Dendritic Cell Antibody supports mapping of antigen presentation pathways.
Dendritic Cell Antibodies clarify interactions between DCs and T cells in initiating adaptive responses.
Dendritic Cell Antibodies highlight DC responses to viral, bacterial, and parasitic infections.
The Dendritic Cell Antibody supports studies of HIV, influenza, and hepatitis pathogenesis.
Dendritic Cell Antibodies provide insight into host–pathogen interactions.
Dendritic Cell Antibodies are applied in tumor immunology to study how DCs shape anti-tumor immunity.
The Dendritic Cell Antibody helps evaluate the efficacy of DC-based cancer vaccines.
Dendritic Cell Antibodies monitor immune responses in immunotherapy clinical trials.
Dendritic Cell Antibodies clarify DC roles in tolerance induction.
The Dendritic Cell Antibody supports research into autoimmune diseases such as lupus and multiple sclerosis.
Dendritic Cell Antibodies help identify DC subsets involved in self-tolerance breakdown.
Dendritic Cell Antibodies are essential in research on adjuvants and vaccine platforms.
The Dendritic Cell Antibody tracks antigen uptake and presentation during vaccination.
Dendritic Cell Antibodies support translational research into next-generation vaccines.
Dendritic Cell Antibodies validate differentiation of stem cells into functional DCs.
The Dendritic Cell Antibody ensures lineage specification in vitro models.
Dendritic Cell Antibodies are applied in regenerative approaches to immune system repair.
Dendritic Cell Antibodies are validated in biomarker discovery for immunotherapy.
The Dendritic Cell Antibody supports monitoring of DC function in clinical trials.
Dendritic Cell Antibodies are increasingly applied in precision medicine strategies.
Dendritic cells orchestrate immunity, tolerance, and disease outcomes. The Dendritic Cell Antibody provides a precise tool for identifying and characterizing DCs, while Dendritic Cell Antibodies more broadly support immunology, oncology, infectious disease, and vaccine research.
In basic immunology, Dendritic Cell Antibodies clarify DC subset identity and antigen presentation pathways. In infection biology, the Dendritic Cell Antibody highlights how pathogens exploit or evade DC functions. In cancer research, Dendritic Cell Antibodies support the design and monitoring of immunotherapies.
Clinically, dendritic cells are being harnessed as therapeutic tools in cancer vaccines and immunotherapies. The Dendritic Cell Antibody ensures reliable identification and monitoring of these cells, bridging discovery biology with clinical innovation.
Dendritic cells are essential regulators of immunity, linking innate recognition to adaptive responses. The Dendritic Cell Antibody equips scientists and clinicians with a validated reagent for studying DC biology, while Dendritic Cell Antibodies more broadly support advances in immunology, oncology, and vaccine development. By ensuring specificity and reproducibility, these antibodies remain indispensable for advancing immune research and improving patient care.
IHC staining of FFPE human spleen tissue with CD35 antibody (clone CR1/6378, Cat # V9752) at 2ug/ml.